From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

被引：4
|
作者：
Thatcher, Thomas H. [1 ]
Peters-Golden, Marc [2 ]
机构：
[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA
[2] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 05期
关键词：
THROMBOXANE A(2); RECEPTOR;
D O I：
10.1164/rccm.202205-0914ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530 / 532
页数：4
相关论文
共 50 条
  • [11] Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
    Machahua, Carlos
    Guler, Sabina A.
    Horn, Michael P.
    Planas-Cerezales, Lurdes
    Montes-Worboys, Ana
    Geiser, Thomas K.
    Molina-Molina, Maria
    Funke-Chambour, Manuela
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [12] S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis
    Lee, Jong-Uk
    Kim, Min Kyung
    Kim, Myung-Shin
    Lee, Sun Ju
    Park, Seung-lee
    Chang, Hun Soo
    Park, Jong-Sook
    Park, Choon-Sik
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (01)
  • [13] Mechanism of dact2 gene inhibiting the occurrence and development of liver fibrosis
    Huang, Shen'an
    Qian, Xia
    Jiang, Ting
    Xiao, Jing
    Yin, Min
    Xiong, Ming
    Wen, Zhili
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (06) : 33 - 39
  • [14] Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis
    Uhal, Bruce D.
    Dang, MyTrang
    Dang, Vinh
    Llatos, Roger
    Cano, Esteban
    Abdul-Hafez, Amal
    Markey, Jonathan
    Piasecki, Christopher C.
    Molina-Molina, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (01) : 198 - 210
  • [15] Nrf2 mediates the effects of shionone on silica-induced pulmonary fibrosis
    Wang, Guiyun
    Xie, Weixi
    Deng, Lang
    Huang, Xiaoting
    Sun, Mei
    Liu, Wei
    Tang, Siyuan
    CHINESE MEDICINE, 2024, 19 (01):
  • [16] Emerging role of BMPs/BMPR2 signaling pathway in treatment for pulmonary fibrosis
    Ye, Qinmao
    Taleb, Sarah J.
    Zhao, Jing
    Zhao, Yutong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [17] Diminished Prostaglandin E2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary Fibrosis
    Maher, Toby M.
    Evans, Iona C.
    Bottoms, Stephen E.
    Mercer, Paul F.
    Thorley, Andrew J.
    Nicholson, Andrew G.
    Laurent, Geoffrey J.
    Tetley, Teresa D.
    Chambers, Rachel C.
    McAnulty, Robin J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (01) : 73 - 82
  • [18] Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism
    Wang, Yi-Jun
    Xie, Xiao-Li
    Liu, Hong-Qun
    Tian, Hui
    Jiang, Xiao-Yu
    Zhang, Jiu-Na
    Chen, Sheng-Xiong
    Liu, Ting
    Wang, Shu-Ling
    Zhou, Xue
    Jin, Xiao-Xu
    Liu, Shi-Mao
    Jiang, Hui-Qing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (39) : 5452 - 5470
  • [19] Circulating ST2, from biomarker to pathogenic mediator
    Pascual-Figal, Domingo
    Lax, Antonio
    Lopez, Maria Carmen Asensio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (09): : 672 - 674
  • [20] Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis
    Parra, Edwin Roger
    Pinto Ruppert, Aline Domingos
    Capelozzi, Vera Luiza
    CLINICS, 2014, 69 (01) : 47 - 54
12345